Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

NCT02811978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Janssen Research & Development, LLC